When Brian Hanley set out to test a gene therapy, he started with himself.
Nobel Prize winners lend their faces, credibility, to supplement maker Elysium’s advertising campaign.
The technique could be faster and more versatile than developing genetically modified crops from scratch.
Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach.
A vaccine against the deadly virus has passed a key testing milestone, but it’s not a long-term solution to stop it.
Researchers have tested a modified malaria parasite in humans that has been shown to be safe and to trigger an immune response.
If you would like to update the frequency or type of newsletters received, please edit your newsletter preferences or unsubscribe from all MIT Technology Review communications.MIT Technology ReviewOne Main StreetCambridge, MA 02142